Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from CK Life Sciences International (Holdings), Inc. ( (HK:0775) ) is now available.
CK Life Sciences International (Holdings) Inc. has scheduled a board meeting in Hong Kong on 17 March 2026 to review and approve the annual results for the financial year ended 31 December 2025. The board will also consider the declaration of a final dividend, a decision that could directly affect shareholder returns and signal management’s assessment of the company’s financial health.
The meeting underscores routine but important governance processes for a Hong Kong-listed life sciences company with a board comprising both executive and independent non-executive directors. Investors will watch the outcome for insight into profitability, cash generation and capital allocation priorities following the close of the 2025 financial year.
The most recent analyst rating on (HK:0775) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on CK Life Sciences International (Holdings), Inc. stock, see the HK:0775 Stock Forecast page.
More about CK Life Sciences International (Holdings), Inc.
CK Life Sciences International (Holdings) Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates in the life sciences sector, focusing on research-driven products and technologies aimed at healthcare, agriculture and environmental improvement. The company serves regional and global markets, leveraging scientific innovation under the wider CK group umbrella.
Average Trading Volume: 7,285,195
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.59B
Learn more about 0775 stock on TipRanks’ Stock Analysis page.